Gabriela Chiosis - Concepedia

Author

Gabriela Chiosis

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

Chiosis, G., Chiosis, Gabriela, G Chiosis, G. Chiosis, Gabriela Chiosis, Gabriela Chiosis, Lynes, Michael

380

Publications

14.9K

Citations

H-Index

151

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University Kettering University Hauptman-Woodward Medical Research Institute

About

Gabriela Chiosis is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, cell biology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	60	5.9K
2	Natural Sciences	22	26	2.7K
3	Engineering	10	10	592
4	Health Sciences	4	4	242
5	Social Sciences	1	1	81

Gabriela Chiosis

130

Publications

11K

Citations

H-Index

Page 1

	Year	Citations
Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators Haley Hieronymus, Justin Lamb, Kenneth N. Ross, Cancer Cell BioinformaticsSystems BiologyNatural SciencesGeneticsComputational Biology	2006	621
Akt Forms an Intracellular Complex with Heat Shock Protein 90 (Hsp90) and Cdc37 and Is Destabilized by Inhibitors of Hsp90 Function Andrea Basso, David B. Solit, Gabriela Chiosis, Journal of Biological Chemistry	2002	620
Heterodimeric JAK–STAT activation as a mechanism of persistence to JAK2 inhibitor therapy Priya Koppikar, Neha Bhagwat, Outi Kilpivaara, Nature	2012	359
New Arylthioindoles: Potent Inhibitors of Tubulin Polymerization. 2. Structure−Activity Relationships and Molecular Modeling Studies Gabriella Martino, Michael Edler, Giuseppe La Regina, Journal of Medicinal Chemistry Pharmaceutical ScienceChemical BiologyPharmaceutical ChemistryMedicinal ChemistryAnti-cancer Agent	2006	356
Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models Eloisi Caldas-Lopes, Leandro Cerchietti, James H. Ahn, Proceedings of the National Academy of Sciences Hsp90 Inhibitor Pu-h71Breast OncologyComplete ResponsesTnbc TumorsMedicine	2009	309
The epichaperome is an integrated chaperome network that facilitates tumour survival Anna Rodina, Tai Wang, Pengrong Yan, Nature Tumor BiologyMedicineNatural SciencesPathologyCancer Genomics	2016	293
Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms Raajit K. Rampal, Jihae Ahn, Omar Abdel‐Wahab, Proceedings of the National Academy of Sciences	2014	292
A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells Gabriela Chiosis, Merna N. Timaul, Brian S. Lucas, Chemistry & Biology Cell RegulationHer2 DegradationMolecular BiologyBreast CancerMolecular Basis	2001	284
BCR-ABL point mutants isolated from patients with imatinib mesylate–resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90 M. Gorre, Katharine Ellwood‐Yen, Gabriela Chiosis, Blood	2002	278
Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies Wenjie Luo, Fei Dou, Anna Rodina, Proceedings of the National Academy of Sciences Molecular BiologyHeat-shock Protein 90Neurochemical BiomarkersTau ProteinAlzheimer's Disease	2007	273

Page 1